RYTHMOL
LOE ApproachingNDAORALTABLET
Approved
Nov 1989
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed Yesterday · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
RYTHMOL (generic name unknown) is an oral tablet small-molecule drug approved by GSK in 1989 for cardiac arrhythmia management. The exact mechanism of action and indications are not specified in available data, but the product represents a mature, established therapeutic option in the antiarrhythmic class.
LOE Approaching
Product is in late-stage lifecycle with LOE approaching; commercial team focus is likely on maintenance, cost management, and transition planning rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites
Started Apr 2012
38 enrolled
Arrhythmia, Cardiac
Career Relevance
Working on RYTHMOL offers stability and deep therapeutic expertise in a well-established cardiac franchise, but limited growth or innovation opportunity. Career value lies in commercial optimization, patient advocacy, and managed market navigation in a mature product lifecycle stage.
Brand Manager
Worked on RYTHMOL at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.